Macrophage depletion induced by clodronate-loaded erythrocytes

Journal of Drug Targeting

Volumn 13, Issue 2, 2005, Pages 99-111

  Rossi, Luigia ^a   Serafini, Sonja ^a   Antonelli, Antonella ^a   Pierigé, Francesca ^a   Carnevali, Andrea ^b   Battistelli, Valeria ^a   Malatesta, Manuela ^a   Balestra, Emanuela ^c   Caliò, Raffaele ^c   Perno, Carlo Federico ^c   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autoimmune hemolytic anemia; Clodronate; Immunothrombocytopenia; Macrophages

Indexed keywords

CLODRONIC ACID;

ANIMAL CELL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CELL ADHESION; CELL SPECIFICITY; CONCENTRATION RESPONSE; DIALYSIS; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ERYTHROCYTE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; CELL ADHESION; CLODRONIC ACID; DRUG CARRIERS; DRUG STABILITY; ERYTHROCYTES; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; SPLEEN;

EID: 20244385810     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860500064123     Document Type: Article

References (45)

1. Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, et al. 2000. Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheu 29:228-251.
2. Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA. 2000. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 96:2834-2840.
3. Alves-Rosa F, Vermeulen M, Cabrera J, Stanganelli C, Capozzo A, Narbaitz M, van Roojen N, Palermo M. 2003. Macrophage depletion following liposomal-encapsulated clodronate (LIP-CLOD) injection enhances megakaryocytopoietic and thrombopoietic activities in mice. Br J Haematol 121:130-138.
4. Auriola S, Frith JC, Rogers MJ, Koivuniemi A, Mönkkönen J. 1997. Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion pair liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 704:187-195.
5. Barrera P, Blom A, van Lent PL, van Bloois L, Beijnen JH, van Rooijen N, de Waal Malefijt MC, van de Putte LB, Storm G, van den Berg WB. 2000. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum 43:1951-1959.
6. Beutler E. 1984. In: Grune and Stratton, editors. Red blood cell metabolism: A manual of biochemical methods. 3rd ed. New York.
7. Fleish H. 1991. Bisphosphonates: Pharmacology and use in the treatment of tumor induced hypercalcaemia and metastatic bone disease. Drugs 42:919-944.
8. Fox A, Koulmanda M, Mandel TE, van Rooijen N, Harrison LC. 1998. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 66:1407-1416.
9. Fraternale A, Rossi L, Magnani M. 1996. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes. Biochim Biophys Acta 1291:149-154.
10. Frith JC, Mönkkönen J, Blackburn GM, Russel RG, Rogers MJ. 1997. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(β,γ-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12:1358-1367.
11. Hoch JR, Stark VK, van Rooijen N, Kim JL, Nutt MP, Warner TF. 1999. Macrophage depletion alters vein graft intimal hyperplasia. Surgery 126:428-437.
12. Kanis JA, O'Rourke N, McCloskey EV. 1994. Consequences of neoplasia induced bone resorption and the use of clodronate (review). Int J Oncol 5:713-731.
13. Khan SA, McCloskey EV, Eyres KS, Nakatsuka K, Sirtori P, Orgee J, Coombes G, Kanis JA. 1996. Comparison of three intravenous regimens of clodronate in Paget disease of bone. J Bone Miner Res 11:178-182.
14. Lehenkari PP, Kellinsalmi M, Näpänkangas JP, Ylitalo KV, Mönkkönen J, Rogers MJ, Azhayev A, Väänänen HK, Hassinen IE. 2002. Further insight into mechanism of action of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol Pharmacol 62:1255-1262.
15. van Lent PL, Holthuysen AE, van den Bersselaar LA, van Rooijen N, Joosten LA, van de Loo FA, van de Putte LB, van den Berg WB. 1996. Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis. Arthritis Rheum 39:1545-1555.
16. Magnani M, Rossi L, Brandi G, Schiavano GF, Montroni M, Pierdimonte G. 1992. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies. Proc Natl Acad Sci 89:6477-6481.
17. Magnani M, Rossi L, Fraternale A, Casabianca A, Brandi G, Benatti U, De Flora A. 1997. Targeting antiviral nucleotide analogues to macrophages. J Leukoc Biol 62:133-137.
18. Magnani M, Rossi L, D'Ascenzo M, Panzani I, Bigi L, Zanella A. 1998. Erythrocyte engineering for drug delivery and targeting. Biotechnol Appl Biochem 28:1-6.
19. Magnani M, Rossi L, Fraternale A, Bianchi M, Antonelli A, Crinelli R, Chiarantini L. 2002a. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther 9:749-751.
20. Magnani M, Rossi L, Serafini S. 2002b. Targeting drug loaded red blood cells. In: Magnani M, editor. Erythrocyte engineering for drug delivery and targeting. Texas: Landes Bioscience. p 29-37.
21. Makkonen N, Salaminen A, Rogers MJ, Frith JC, Urtti A, Azhayeva E, Mönkkönen J. 1999. Contrasting effects of alendronate and clodronate on Raw 264 macrophages: The role of bisphosphonate metabolite. Eur J Pharm Sci 8:109-118.
22. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD. 1999. Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines. International committee for osteoporosis clinical guidelines. Clin Ther 21:1025-1044.
23. Mönkkönnen J, Urtti A, Paronen P, Elo HA, Ylitalo P. 1989. The uptake of clodronate (dichloromethilene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab Dispos 17:690-693.
24. Mönkkönnen J, van Roojen N, Pauli Ylitalo. 1991. Effects of clodronate and pamidronate on splenic and hepatic phagocytic cells of mice. Pharmacol Toxicol 68:284-286.
25. Naito M, Nagai H, Kawano S, Umezu H, Zhu H, Moriyama H, Yamamoto T, Takatsuka H, Takei Y. 1996. Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J Leukoc Biol 60:337-344.
26. 31P NMR study. Biochem Pharmacol 44:2157-2163.
27. Perno CF, Balestra E, Aquaro S, Panti S, Cenci A, Lazzarino G, Tavazzi B, Di Pietro D, Balzarini J, Caliò R. 1996. The potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in primary macrophages is determined by drug metabolism, nucleotide pools and cytokines. Mol Pharmacol 50:359-366.
28. Plosker GL, Gao KL. 1994. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 47:945-982.
29. Rogers MJ, Ji X, Russel RG, Blackburn GM, Williamson MP, Bayless AV, Ebetino FH, Watts DJ. 1994. Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum. Biochem J 303:303-311.
30. Rogers MJ, Chilton KM, Coxon FP, Lawry J, Smith MO, Suri S, Russel RG. 1996. Bisphosphonates induce apoptosis in mouse macrophages-like cells in vitro by a nitric oxide-independent mechanism. J Bone Miner Res 11:1482-1491.
31. van Rooijen N, van Nieuwmegen R. 1984. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosponate. An enzyme-histochemica study. Cell Tissue Res 238:355-358.
32. van Rooijen N, Sanders A. 1994. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174:83-93.
33. van Rooijen N, Kors N, ter Hart H, Claassen E. 1988. In vitro and in vivo elimination of macrophage tumor cells using liposome-encapsulated dichloromethylene diphosponate. Virchows Archiv B Cell Pathol 54:241-245.
34. van Rooijen N, Sanders A, van den Berg TK. 1996. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 193:93-99.
35. van Rooijen N, Bakker J, Sanders A. 1997. Transient suppression of macrophage functions by liposome-encapsulated drugs. Tibtech 15:178-184.
36. Rossi L, Brandi G, Schiavano GF, Scarfi S, Millo E, Damonte G, Benatti U, De Flora A, Magnani M. 1999. Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol. AIDS Res Hum Retroviruses 15:345-353.
37. Rossi L, Serafini S, Cenerini L, Picardi F, Bigi L, Panzani I, Magnani M. 2001a. Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease. Biotechnol Appl Biochem 33:85-89.
38. Rossi L, Serafini S, Cappellacci L, Balestra E, Brandi G, Schiavano GF, Franchetti P, Grifantini M, Perno CF, Magnani M. 2001b. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus. J Antimicrob Chemother 47:819-827.
39. Rossi L, Castro M, D'Orio F, Damonte G, Serafini S, Bigi L, Panzani I, Novelli G, Dalla Piccola B, Panunzi S, et al. 2004a. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients. Blood Cell Mol Dis 33:57-63.
40. Rossi L, Brandi G, Malatesta M, Serafini S, Pierigè F, Celeste AG, Schiavano GF, Gazzanelli G, Magnani M. 2004b. Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages. J Antimicrob Chemother 53:863-866.
41. Schmidt-Weber CB, Rittig M, Buchner E, Hauser I, Schmidt I, Palombo-Kinne E, Emmrich F, Kinne RW. 1996. Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. J Leukoc Biol 60:230-244.
42. Serafini S, Rossi L, Antonelli A, Fraternale A, Cerasi A, Crinelli R, Chiarantini L, Schiavano GF, Magnani M. 2004. Drug delivery through phagocytosis of red blood cells. Transfus Med Hemoth 31:92-101.
43. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161:3767-3775.
44. Van der Veen G, Broersma L, Dijkstra CD, Van Rooijen N, Van Rij G, Van der Gaag R. 1994. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest Ophthalmol Vis Sci 35:3505-3515.
45. Wu G, Korsgren O, Zhang J, Song Z, van Rooijen N, Tibell A. 2000. Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: A study in streptozotocin diabetic animals. Xenotransplantation 7:214-220.